Maxcyte, Inc.: Form 10-K/A for the period ended Dec 31, 2021
Filed with the SEC on Apr 29, 2022 and accepted by EDGAR at Apr 29, 2022, 16:27 ET.
Sections
No standard item headings were found in this filing’s main document, so no sections were extracted. Read the original on sec.gov. The main document on sec.gov.
Source: SEC EDGAR, the filing index for accession 0001104659-22-053626. Last ingested by Listed: Nov 11, 2026, 01:53 ET. Listed shows no prices and gives no investment advice.